FDA Inspection 759166 — Aesica Pharmaceuticals GmbH
The FDA completed an inspection of Aesica Pharmaceuticals GmbH on November 8, 2011 in Zwickau. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 8, 2011
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Zwickau (Germany)